Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2013 1
2014 8
2015 13
2016 8
2017 17
2018 22
2019 17
2020 13
2021 8
2022 10
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean young woo jeong (4 results)?
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1.
Park S, Bang SY, Kwag D, Lee JH, Kim TY, Lee J, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Kim HJ. Park S, et al. Among authors: jeon yw. Bone Marrow Transplant. 2024 Mar 4. doi: 10.1038/s41409-024-02255-w. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38438648
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001).
Park SS, Shin SH, Lee JY, Jeon YW, Yhang SA, Min CK. Park SS, et al. Among authors: jeon yw. Cancers (Basel). 2023 Sep 28;15(19):4783. doi: 10.3390/cancers15194783. Cancers (Basel). 2023. PMID: 37835477 Free PMC article.
Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203).
Park SS, Goo SY, Jeon YW, Yhang SA, Shin SH, Min CK. Park SS, et al. Among authors: jeon yw. J Cancer Res Clin Oncol. 2023 Dec;149(18):16279-16291. doi: 10.1007/s00432-023-05385-8. Epub 2023 Sep 12. J Cancer Res Clin Oncol. 2023. PMID: 37698678
Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma.
Choi WH, Han EJ, O JH, Choi EK, Choi JI, Park G, Choi BO, Jeon YW, Min GJ, Cho SG; Catholic University Lymphoma Group. Choi WH, et al. Among authors: jeon yw. Diagnostics (Basel). 2023 Sep 1;13(17):2834. doi: 10.3390/diagnostics13172834. Diagnostics (Basel). 2023. PMID: 37685372 Free PMC article.
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study.
Lee JY, Park SS, Jeon YW, Shin SH, Yahng SA, Min CK; Catholic Research Network for Multiple Myeloma (CAREMM-2102 study). Lee JY, et al. Among authors: jeon yw. J Cancer Res Clin Oncol. 2023 Oct;149(13):11907-11918. doi: 10.1007/s00432-023-04993-8. Epub 2023 Jul 7. J Cancer Res Clin Oncol. 2023. PMID: 37418057
109 results